We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CNTX market cap is 54.82M. The company's latest EPS is USD -0.2979 and P/E is -2.11.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.93M | -3.82M | -3.09M | -18.7M | -4.31M |
| Net Income | -6.77M | -3.67M | -2.25M | -17.46M | -3.34M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -10.53M | -15.88M | -25.07M | -29.92M |
| Net Income | -10.46M | -15.34M | -23.96M | -26.73M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 16.06M | 11.05M | 102.71M | 86.33M | 98.13M |
| Total Liabilities | 4.19M | 2.61M | 1.61M | 2.47M | 2.86M |
| Total Equity | 11.87M | 8.44M | 101.1M | 83.86M | 95.27M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 51.31M | 37.97M | 16.06M | 98.13M |
| Total Liabilities | 3.03M | 3.21M | 4.19M | 2.86M |
| Total Equity | 48.27M | 34.76M | 11.87M | 95.27M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -21.05M | -4.36M | -7.72M | -9.65M | -14.56M |
| Investing | N/A | N/A | N/A | -14.76M | -14.76M |
| Financing | N/A | N/A | 94.8M | 94.76M | 109.29M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.8M | -13.55M | -21.05M | -14.56M |
| Investing | -250k | -537k | N/A | -14.76M |
| Financing | 58.39M | -102k | N/A | 109.29M |
| Market Cap | 54.82M |
| Price to Earnings Ratio | -2.11 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.6 |
| Price to Book Ratio | 0.59 |
| Dividend Yield | - |
| Shares Outstanding | 89.7M |
| Average Volume (1 week) | 742.93k |
| Average Volume (1 Month) | 391.84k |
| 52 Week Change | -69.45% |
| 52 Week High | 2.75 |
| 52 Week Low | 0.49 |
| Spread (Intraday) | 1.04 (63.01%) |
| Company Name | Context Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.contexttherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
